Media Coverage

December 1, 2009 Dr. Fahar Merchant, President & CEO, Protox therapeutics, presents at the Toronto Board of Trade
February 27, 2009 New shot may be best medicine for prostate cancer - Springfield, MO, KY3 NBC News
October 28, 2008 Dr. Fahar merchant, President & CEO, Protox therapeutics, interviewed on BTV
Mar 26, 2008 Dr. Fahar Merchant, President and CEO, Protox Therapeutics interiewed on BNN Small Caps
Mar 28, 2007 Dr. Fahar Merchant interviewed on BNN
July 1, 2006 Dr. Fahar Mechant featured on Market Matters Radio with host Michael Levy.
Mar 27, 2006 Dr. Fahar Mechant featured on CEO Clips on The Biography Channel
Mar 2, 2006 Cancer Research Institute starts first Phase I clinical trial,
New drug targets prostate cancer cells
Mar 2, 2006 Scott & White interview on CBS
Mar 1, 2006 Scott & White interview on NBC

What's New

February 25, 2010
Protox Revises Terms Of Private Placement

February 24, 2010
Protox To Present At The Third International Symposium On Focal Therapy And Imaging Of Prostate And Kidney Cancer

February 4, 2010
Protox Announces Private Placement

January 11, 2010
Protox Announces Positive Phase 2B BPH Results

 

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.48
TRADE TIME:3:55PM EST
CHANGE:$0.04 (9.09%)
PREV CLOSE: $0.44
OPEN:$0.45
BID:$0.46
ASK:$0.48